🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the efficacy and safety of U3-1402 in participa...
Status
Recruiting
Location
Centre Georges François Leclerc
Start Date
2021-05-11
Trial ID
NCT04965766
Treatments Being Tested
This study is a Phase 1/2, first-in-human, open-label, clinical trial to as...
Status
Recruiting
Location
Research Site
Start Date
2025-12-17
Trial ID
NCT06956690
Treatments Being Tested
RATIONALE: Patients with HER2-negative advanced breast cancer have limited ...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2023-11-01
Trial ID
NCT06121557
This is a Phase 3, open label, randomized study designed to compare the saf...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-03-02
Trial ID
NCT02631876
Treatments Being Tested
An expanded access/compassionate use protocol that allows access to Mylotar...
Status
No Longer Available
Location
University of Alabama at Birmingham/Children's of Alabama
Start Date
TBD
Trial ID
NCT02312037
Treatments Being Tested
This prospective, multicenter clinical study aims to evaluate the efficacy ...
Status
Recruiting
Location
Eye & ENT Hospital of Fudan University
Start Date
2026-04-28
Trial ID
NCT07522879
Treatments Being Tested
This Phase 3 study is designed to compare the efficacy and safety of mirvet...
Status
Completed
Location
University of Alabama at Birmingham (UAB) GYN Oncology
Start Date
2019-12-31
Trial ID
NCT04209855
Treatments Being Tested
This research is designed to determine if experimental treatment with PARP ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-11-12
Trial ID
NCT04644068
Treatments Being Tested